{"id":7651,"date":"2016-03-22T13:19:00","date_gmt":"2016-03-22T17:19:00","guid":{"rendered":"http:\/\/bio-04.eproofs.ca\/sensibilisation-et-politiques\/biotechnologie-de-la-sante\/"},"modified":"2025-02-04T08:52:07","modified_gmt":"2025-02-04T13:52:07","slug":"biotechnologie-de-la-sante","status":"publish","type":"page","link":"https:\/\/www.biotech.ca\/fr\/sensibilisation-et-politiques\/biotechnologie-de-la-sante\/","title":{"rendered":"Biotechnologie de la sant\u00e9"},"content":{"rendered":"\n

Le r\u00e9gime de r\u00e9glementation du Canada doit \u00eatre adapt\u00e9 aux changements majeurs du secteur des soins de sant\u00e9. La modernisation des m\u00e9thodes de r\u00e9glementation sera une assurance pour le Canada d\u2019offrir aux Canadiens le meilleur des d\u00e9couvertes et des recherches en sant\u00e9.<\/p>\n\n\n\n

Demain ne peut attendre<\/h2>\n\n\n\n

Les syst\u00e8mes de sant\u00e9 du Canada l\u2019occasion d\u2019\u00e9voluer et de profiter des innovations \u00e0 venir dans le traitement du cancer. La r\u00e9ponse du Canada \u00e0 la pand\u00e9mie a d\u00e9montr\u00e9 qu\u2019il est possible de travailler de concert et de mettre en \u0153uvre rapidement et facilement des solutions \u00e0 des probl\u00e8mes importants.<\/p>\n\n\n\n

Au cours des dix derni\u00e8res ann\u00e9es, plusieurs traitements novateurs contre le cancer ont \u00e9t\u00e9 approuv\u00e9s rapidement par les organismes de r\u00e9glementation et les organismes ax\u00e9s sur les technologies de la sant\u00e9.<\/p>\n\n\n\n

Les avanc\u00e9es scientifiques ont consid\u00e9rablement am\u00e9lior\u00e9 les r\u00e9sultats pour les patients gr\u00e2ce \u00e0 des d\u00e9couvertes qui attaquent le cancer aux niveaux cellulaire et g\u00e9n\u00e9tique. L\u2019innovation est tr\u00e8s pr\u00e9sente dans les soins apport\u00e9es aux personnes atteintes du cancer et plusieurs nouveaux traitement se dessinent \u00e0 l\u2019horizon. Apprendre encore plus<\/a>.<\/p>\n\n\n\n

Optimisation de l’acc\u00e8s des patients aux th\u00e9rapies de pr\u00e9cision<\/h2>\n\n\n\n

Il existe des possibilit\u00e9s \u00e9videntes d\u2019accro\u00eetre la pr\u00e9paration de l\u2019ensemble du syst\u00e8me aux tests de diagnostic novateurs afin d\u2019am\u00e9liorer les r\u00e9sultats sur la sant\u00e9, de mettre en place une infrastructure sanitaire, y compris un approvisionnement national fiable, et de positionner le pays pour qu\u2019il b\u00e9n\u00e9ficie des investissements futurs en recherche et d\u00e9veloppement.<\/p>\n\n\n\n

Le Canada peut devenir un chef de file international dans ce domaine si les gouvernements f\u00e9d\u00e9ral et provinciaux, les organismes d\u2019\u00e9valuation des technologies de la sant\u00e9 (ETS), l\u2019industrie et d\u2019autres parties prenantes travaillent ensemble pour faire en sorte que le cadre strat\u00e9gique \u00e9volue au rythme de la science. Apprendre encore plus. <\/a><\/p>\n\n\n\n

Acc\u00e8s Aux Traitements Innovants<\/h2>\n\n\n\n

Les soci\u00e9t\u00e9s de biotechnologie innovantes qui mettent au point des traitements avanc\u00e9s ont des obstacles \u00e0 surmonter pour faire parvenir leurs produits aux patients canadiens. L\u2019acc\u00e8s restreint au march\u00e9 et la lente adoption des nouvelles technologies ont de graves cons\u00e9quences pour les Canadiens. BIOTECanada travaille avec les organismes d\u2019examen f\u00e9d\u00e9raux, provinciaux et territoriaux tels que le Programme commun d\u2019\u00e9valuation des m\u00e9dicaments (PCEM) \u00e0 cr\u00e9er un environnement meilleur pour l\u2019adoption de traitements qui constituent des perc\u00e9es et pour une plus grande reconnaissance de la valeur de l\u2019innovation.<\/p>\n\n\n\n

<\/h2>\n\n\n\n

\u00c9laboration D\u2019une Politique Canadienne Sur Les Produits Orphelins<\/h2>\n\n\n\n

Les Canadiens qui vivent avec une maladie orpheline ont droit au m\u00eame acc\u00e8s aux interventions salvatrices que les citoyens des autres pays. BIOTECanada travaille avec tous les paliers de gouvernement et avec des partenaires cl\u00e9s \u00e0 \u00e9laborer une politique sur les produits orphelins qui soit anticipatrice, en tenant compte des param\u00e8tres l\u00e9gislatifs et r\u00e9glementaires pertinents, afin de s\u2019assurer que les Canadiens aient acc\u00e8s aux traitements dont ils ont besoin et que les soci\u00e9t\u00e9s soient incit\u00e9es \u00e0 mettre au point et \u00e0 commercialiser des produits destin\u00e9s aux maladies orphelines.<\/p>\n\n\n\n

Produits Biologiques Ult\u00e9rieurs (PBU)<\/h2>\n\n\n\n

Le terme produits biologiques ult\u00e9rieurs (PBU) est utilis\u00e9 par Sant\u00e9 Canada pour d\u00e9crire \u00ab un produit biologique qui est semblable \u00e0 un produit biologique approuv\u00e9 de l\u2019innovateur et qui fait son apparition sur le march\u00e9 apr\u00e8s celui-ci \u00bb. Le minist\u00e8re \u00e9value actuellement le processus r\u00e9glementaire selon lequel de tels produits recevraient une licence de commercialisation au Canada.<\/p>\n\n\n\n

BIOTECanada soutient la cr\u00e9ation d\u2019une voie r\u00e9glementaire pour les PBU qui int\u00e8gre des processus et des exigences prot\u00e9geant la s\u00e9curit\u00e9 des patients.<\/p>\n\n\n\n

Les membres de BIOTECanada ont mis au point un ensemble de principes qui, selon l\u2019industrie de la biotechnologie, devraient orienter la r\u00e9glementation des PBU et leur introduction dans le march\u00e9 canadien.<\/p>\n","protected":false},"excerpt":{"rendered":"

Le r\u00e9gime de r\u00e9glementation du Canada doit \u00eatre adapt\u00e9 aux changements majeurs du secteur des soins de sant\u00e9. La modernisation des m\u00e9thodes de r\u00e9glementation sera une assurance pour le Canada<\/p>\n

Lire la suite<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":7619,"menu_order":490,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"rank_math_lock_modified_date":false,"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"class_list":["post-7651","page","type-page","status-publish","entry"],"acf":[],"rankMath":{"parentDomain":"www.biotech.ca","noFollowDomains":[],"noFollowExcludeDomains":[],"noFollowExternalLinks":false,"featuredImageNotice":"L\u2019image en vedette devrait \u00eatre au moins 200 par 200 pixels pour \u00eatre utilis\u00e9 par Facebook et d\u2019autres sites de m\u00e9dias sociaux.","pluginReviewed":false,"postSettings":{"linkSuggestions":true,"useFocusKeyword":false},"frontEndScore":false,"postName":"biotechnologie-de-la-sante","permalinkFormat":"https:\/\/www.biotech.ca\/fr\/%pagename%\/","showLockModifiedDate":true,"assessor":{"focusKeywordLink":"https:\/\/www.biotech.ca\/wp-admin\/edit.php?focus_keyword=%focus_keyword%&post_type=%post_type%","hasTOCPlugin":false,"primaryTaxonomy":false,"serpData":{"title":"Biotechnologie de la sant\u00e9 - BIOTECanada","description":"Le r\u00e9gime de r\u00e9glementation du Canada doit \u00eatre adapt\u00e9 aux changements majeurs du secteur des soins de sant\u00e9. La modernisation des m\u00e9thodes de r\u00e9glementation sera une assurance pour le Canada... Lire la suite \u00bb","focusKeywords":"","pillarContent":false,"canonicalUrl":"","breadcrumbTitle":"","advancedRobots":{"max-snippet":"-1","max-video-preview":"-1","max-image-preview":"large"},"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":"","facebookHasOverlay":false,"facebookImageOverlay":"","facebookAuthor":"","twitterCardType":"","twitterUseFacebook":true,"twitterTitle":"","twitterDescription":"","twitterImage":"","twitterImageID":"","twitterHasOverlay":false,"twitterImageOverlay":"","twitterPlayerUrl":"","twitterPlayerSize":"","twitterPlayerStream":"","twitterPlayerStreamCtype":"","twitterAppDescription":"","twitterAppIphoneName":"","twitterAppIphoneID":"","twitterAppIphoneUrl":"","twitterAppIpadName":"","twitterAppIpadID":"","twitterAppIpadUrl":"","twitterAppGoogleplayName":"","twitterAppGoogleplayID":"","twitterAppGoogleplayUrl":"","twitterAppCountry":"","robots":{"index":true},"twitterAuthor":"BIOTECanada","primaryTerm":0,"authorName":"envision","titleTemplate":"%title% %page% %sep% %sitename%","descriptionTemplate":"%excerpt%","showScoreFrontend":true,"lockModifiedDate":false},"powerWords":["absolument","amazement","astonishing","authentique","beau","bien-\u00eatre","brillant","captivant","charismatique","choc","clair","compl\u00e8tement","confidentiel","confiance","cons\u00e9quent","cr\u00e9atif","d\u00e9finitivement","d\u00e9licieux","d\u00e9montrer","d\u00e9p\u00eachez-vous","d\u00e9termin\u00e9","digne","dynamique","\u00e9blouissant","\u00e9clatant","\u00e9conomique","\u00e9fficace","\u00e9l\u00e9gant","\u00e9motionnel","\u00e9nergique","\u00e9norme","\u00e9poustouflant","essentiel","\u00e9tonnant","exclusif","exp\u00e9rience","fabuleux","fantastique","formidable","fort","garanti","g\u00e9ant","g\u00e9n\u00e9reux","grandiose","gratuit","habile","harmonieux","historique","hors pair","important","incroyable","indispensable","inoubliable","inspirant","innovant","intense","invention","irr\u00e9sistible","l\u00e9gendaire","lumineux","luxe","magique","magnifique","majestueux","marquant","merveilleux","miraculeux","motivant","n\u00e9cessaire","nouvelle","officiel","parfait","passionn\u00e9","persuasif","ph\u00e9nom\u00e9nal","plaisir","populaire","pouvoir","prestigieux","prodigieux","profond","prosp\u00e8re","puissant","qualit\u00e9","radieux","rapide","r\u00e9ussi","r\u00e9volutionnaire","satisfait","s\u00e9curit\u00e9","sensationnel","serein","somptueux","splendide","sublime","surprenant","talentueux","terrifiant","unique","valeur","vibrant","victorieux","vif","vraiment","z\u00e9l\u00e9"],"diacritics":{"A":"[\\u0041\\u24B6\\uFF21\\u00C0\\u00C1\\u00C2\\u1EA6\\u1EA4\\u1EAA\\u1EA8\\u00C3\\u0100\\u0102\\u1EB0\\u1EAE\\u1EB4\\u1EB2\\u0226\\u01E0\\u00C4\\u01DE\\u1EA2\\u00C5\\u01FA\\u01CD\\u0200\\u0202\\u1EA0\\u1EAC\\u1EB6\\u1E00\\u0104\\u023A\\u2C6F]","AA":"[\\uA732]","AE":"[\\u00C6\\u01FC\\u01E2]","AO":"[\\uA734]","AU":"[\\uA736]","AV":"[\\uA738\\uA73A]","AY":"[\\uA73C]","B":"[\\u0042\\u24B7\\uFF22\\u1E02\\u1E04\\u1E06\\u0243\\u0182\\u0181]","C":"[\\u0043\\u24B8\\uFF23\\u0106\\u0108\\u010A\\u010C\\u00C7\\u1E08\\u0187\\u023B\\uA73E]","D":"[\\u0044\\u24B9\\uFF24\\u1E0A\\u010E\\u1E0C\\u1E10\\u1E12\\u1E0E\\u0110\\u018B\\u018A\\u0189\\uA779]","DZ":"[\\u01F1\\u01C4]","Dz":"[\\u01F2\\u01C5]","E":"[\\u0045\\u24BA\\uFF25\\u00C8\\u00C9\\u00CA\\u1EC0\\u1EBE\\u1EC4\\u1EC2\\u1EBC\\u0112\\u1E14\\u1E16\\u0114\\u0116\\u00CB\\u1EBA\\u011A\\u0204\\u0206\\u1EB8\\u1EC6\\u0228\\u1E1C\\u0118\\u1E18\\u1E1A\\u0190\\u018E]","F":"[\\u0046\\u24BB\\uFF26\\u1E1E\\u0191\\uA77B]","G":"[\\u0047\\u24BC\\uFF27\\u01F4\\u011C\\u1E20\\u011E\\u0120\\u01E6\\u0122\\u01E4\\u0193\\uA7A0\\uA77D\\uA77E]","H":"[\\u0048\\u24BD\\uFF28\\u0124\\u1E22\\u1E26\\u021E\\u1E24\\u1E28\\u1E2A\\u0126\\u2C67\\u2C75\\uA78D]","I":"[\\u0049\\u24BE\\uFF29\\u00CC\\u00CD\\u00CE\\u0128\\u012A\\u012C\\u0130\\u00CF\\u1E2E\\u1EC8\\u01CF\\u0208\\u020A\\u1ECA\\u012E\\u1E2C\\u0197]","J":"[\\u004A\\u24BF\\uFF2A\\u0134\\u0248]","K":"[\\u004B\\u24C0\\uFF2B\\u1E30\\u01E8\\u1E32\\u0136\\u1E34\\u0198\\u2C69\\uA740\\uA742\\uA744\\uA7A2]","L":"[\\u004C\\u24C1\\uFF2C\\u013F\\u0139\\u013D\\u1E36\\u1E38\\u013B\\u1E3C\\u1E3A\\u0141\\u023D\\u2C62\\u2C60\\uA748\\uA746\\uA780]","LJ":"[\\u01C7]","Lj":"[\\u01C8]","M":"[\\u004D\\u24C2\\uFF2D\\u1E3E\\u1E40\\u1E42\\u2C6E\\u019C]","N":"[\\u004E\\u24C3\\uFF2E\\u01F8\\u0143\\u00D1\\u1E44\\u0147\\u1E46\\u0145\\u1E4A\\u1E48\\u0220\\u019D\\uA790\\uA7A4]","NJ":"[\\u01CA]","Nj":"[\\u01CB]","O":"[\\u004F\\u24C4\\uFF2F\\u00D2\\u00D3\\u00D4\\u1ED2\\u1ED0\\u1ED6\\u1ED4\\u00D5\\u1E4C\\u022C\\u1E4E\\u014C\\u1E50\\u1E52\\u014E\\u022E\\u0230\\u00D6\\u022A\\u1ECE\\u0150\\u01D1\\u020C\\u020E\\u01A0\\u1EDC\\u1EDA\\u1EE0\\u1EDE\\u1EE2\\u1ECC\\u1ED8\\u01EA\\u01EC\\u00D8\\u01FE\\u0186\\u019F\\uA74A\\uA74C]","OI":"[\\u01A2]","OO":"[\\uA74E]","OU":"[\\u0222]","P":"[\\u0050\\u24C5\\uFF30\\u1E54\\u1E56\\u01A4\\u2C63\\uA750\\uA752\\uA754]","Q":"[\\u0051\\u24C6\\uFF31\\uA756\\uA758\\u024A]","R":"[\\u0052\\u24C7\\uFF32\\u0154\\u1E58\\u0158\\u0210\\u0212\\u1E5A\\u1E5C\\u0156\\u1E5E\\u024C\\u2C64\\uA75A\\uA7A6\\uA782]","S":"[\\u0053\\u24C8\\uFF33\\u1E9E\\u015A\\u1E64\\u015C\\u1E60\\u0160\\u1E66\\u1E62\\u1E68\\u0218\\u015E\\u2C7E\\uA7A8\\uA784]","T":"[\\u0054\\u24C9\\uFF34\\u1E6A\\u0164\\u1E6C\\u021A\\u0162\\u1E70\\u1E6E\\u0166\\u01AC\\u01AE\\u023E\\uA786]","TZ":"[\\uA728]","U":"[\\u0055\\u24CA\\uFF35\\u00D9\\u00DA\\u00DB\\u0168\\u1E78\\u016A\\u1E7A\\u016C\\u00DC\\u01DB\\u01D7\\u01D5\\u01D9\\u1EE6\\u016E\\u0170\\u01D3\\u0214\\u0216\\u01AF\\u1EEA\\u1EE8\\u1EEE\\u1EEC\\u1EF0\\u1EE4\\u1E72\\u0172\\u1E76\\u1E74\\u0244]","V":"[\\u0056\\u24CB\\uFF36\\u1E7C\\u1E7E\\u01B2\\uA75E\\u0245]","VY":"[\\uA760]","W":"[\\u0057\\u24CC\\uFF37\\u1E80\\u1E82\\u0174\\u1E86\\u1E84\\u1E88\\u2C72]","X":"[\\u0058\\u24CD\\uFF38\\u1E8A\\u1E8C]","Y":"[\\u0059\\u24CE\\uFF39\\u1EF2\\u00DD\\u0176\\u1EF8\\u0232\\u1E8E\\u0178\\u1EF6\\u1EF4\\u01B3\\u024E\\u1EFE]","Z":"[\\u005A\\u24CF\\uFF3A\\u0179\\u1E90\\u017B\\u017D\\u1E92\\u1E94\\u01B5\\u0224\\u2C7F\\u2C6B\\uA762]","a":"[\\u0061\\u24D0\\uFF41\\u1E9A\\u00E0\\u00E1\\u00E2\\u1EA7\\u1EA5\\u1EAB\\u1EA9\\u00E3\\u0101\\u0103\\u1EB1\\u1EAF\\u1EB5\\u1EB3\\u0227\\u01E1\\u00E4\\u01DF\\u1EA3\\u00E5\\u01FB\\u01CE\\u0201\\u0203\\u1EA1\\u1EAD\\u1EB7\\u1E01\\u0105\\u2C65\\u0250]","aa":"[\\uA733]","ae":"[\\u00E6\\u01FD\\u01E3]","ao":"[\\uA735]","au":"[\\uA737]","av":"[\\uA739\\uA73B]","ay":"[\\uA73D]","b":"[\\u0062\\u24D1\\uFF42\\u1E03\\u1E05\\u1E07\\u0180\\u0183\\u0253]","c":"[\\u0063\\u24D2\\uFF43\\u0107\\u0109\\u010B\\u010D\\u00E7\\u1E09\\u0188\\u023C\\uA73F\\u2184]","d":"[\\u0064\\u24D3\\uFF44\\u1E0B\\u010F\\u1E0D\\u1E11\\u1E13\\u1E0F\\u0111\\u018C\\u0256\\u0257\\uA77A]","dz":"[\\u01F3\\u01C6]","e":"[\\u0065\\u24D4\\uFF45\\u00E8\\u00E9\\u00EA\\u1EC1\\u1EBF\\u1EC5\\u1EC3\\u1EBD\\u0113\\u1E15\\u1E17\\u0115\\u0117\\u00EB\\u1EBB\\u011B\\u0205\\u0207\\u1EB9\\u1EC7\\u0229\\u1E1D\\u0119\\u1E19\\u1E1B\\u0247\\u025B\\u01DD]","f":"[\\u0066\\u24D5\\uFF46\\u1E1F\\u0192\\uA77C]","g":"[\\u0067\\u24D6\\uFF47\\u01F5\\u011D\\u1E21\\u011F\\u0121\\u01E7\\u0123\\u01E5\\u0260\\uA7A1\\u1D79\\uA77F]","h":"[\\u0068\\u24D7\\uFF48\\u0125\\u1E23\\u1E27\\u021F\\u1E25\\u1E29\\u1E2B\\u1E96\\u0127\\u2C68\\u2C76\\u0265]","hv":"[\\u0195]","i":"[\\u0069\\u24D8\\uFF49\\u00EC\\u00ED\\u00EE\\u0129\\u012B\\u012D\\u00EF\\u1E2F\\u1EC9\\u01D0\\u0209\\u020B\\u1ECB\\u012F\\u1E2D\\u0268\\u0131]","j":"[\\u006A\\u24D9\\uFF4A\\u0135\\u01F0\\u0249]","k":"[\\u006B\\u24DA\\uFF4B\\u1E31\\u01E9\\u1E33\\u0137\\u1E35\\u0199\\u2C6A\\uA741\\uA743\\uA745\\uA7A3]","l":"[\\u006C\\u24DB\\uFF4C\\u0140\\u013A\\u013E\\u1E37\\u1E39\\u013C\\u1E3D\\u1E3B\\u017F\\u0142\\u019A\\u026B\\u2C61\\uA749\\uA781\\uA747]","lj":"[\\u01C9]","m":"[\\u006D\\u24DC\\uFF4D\\u1E3F\\u1E41\\u1E43\\u0271\\u026F]","n":"[\\u006E\\u24DD\\uFF4E\\u01F9\\u0144\\u00F1\\u1E45\\u0148\\u1E47\\u0146\\u1E4B\\u1E49\\u019E\\u0272\\u0149\\uA791\\uA7A5]","nj":"[\\u01CC]","o":"[\\u006F\\u24DE\\uFF4F\\u00F2\\u00F3\\u00F4\\u1ED3\\u1ED1\\u1ED7\\u1ED5\\u00F5\\u1E4D\\u022D\\u1E4F\\u014D\\u1E51\\u1E53\\u014F\\u022F\\u0231\\u00F6\\u022B\\u1ECF\\u0151\\u01D2\\u020D\\u020F\\u01A1\\u1EDD\\u1EDB\\u1EE1\\u1EDF\\u1EE3\\u1ECD\\u1ED9\\u01EB\\u01ED\\u00F8\\u01FF\\u0254\\uA74B\\uA74D\\u0275]","oi":"[\\u01A3]","ou":"[\\u0223]","oo":"[\\uA74F]","p":"[\\u0070\\u24DF\\uFF50\\u1E55\\u1E57\\u01A5\\u1D7D\\uA751\\uA753\\uA755]","q":"[\\u0071\\u24E0\\uFF51\\u024B\\uA757\\uA759]","r":"[\\u0072\\u24E1\\uFF52\\u0155\\u1E59\\u0159\\u0211\\u0213\\u1E5B\\u1E5D\\u0157\\u1E5F\\u024D\\u027D\\uA75B\\uA7A7\\uA783]","s":"[\\u0073\\u24E2\\uFF53\\u015B\\u1E65\\u015D\\u1E61\\u0161\\u1E67\\u1E63\\u1E69\\u0219\\u015F\\u023F\\uA7A9\\uA785\\u1E9B]","ss":"[\\u00DF]","t":"[\\u0074\\u24E3\\uFF54\\u1E6B\\u1E97\\u0165\\u1E6D\\u021B\\u0163\\u1E71\\u1E6F\\u0167\\u01AD\\u0288\\u2C66\\uA787]","tz":"[\\uA729]","u":"[\\u0075\\u24E4\\uFF55\\u00F9\\u00FA\\u00FB\\u0169\\u1E79\\u016B\\u1E7B\\u016D\\u00FC\\u01DC\\u01D8\\u01D6\\u01DA\\u1EE7\\u016F\\u0171\\u01D4\\u0215\\u0217\\u01B0\\u1EEB\\u1EE9\\u1EEF\\u1EED\\u1EF1\\u1EE5\\u1E73\\u0173\\u1E77\\u1E75\\u0289]","v":"[\\u0076\\u24E5\\uFF56\\u1E7D\\u1E7F\\u028B\\uA75F\\u028C]","vy":"[\\uA761]","w":"[\\u0077\\u24E6\\uFF57\\u1E81\\u1E83\\u0175\\u1E87\\u1E85\\u1E98\\u1E89\\u2C73]","x":"[\\u0078\\u24E7\\uFF58\\u1E8B\\u1E8D]","y":"[\\u0079\\u24E8\\uFF59\\u1EF3\\u00FD\\u0177\\u1EF9\\u0233\\u1E8F\\u00FF\\u1EF7\\u1E99\\u1EF5\\u01B4\\u024F\\u1EFF]","z":"[\\u007A\\u24E9\\uFF5A\\u017A\\u1E91\\u017C\\u017E\\u1E93\\u1E95\\u01B6\\u0225\\u0240\\u2C6C\\uA763]"},"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasRedirection":true,"hasBreadcrumb":true},"homeUrl":"https:\/\/www.biotech.ca\/fr\/","objectID":7651,"objectType":"post","locale":"fr","localeFull":"fr_FR","overlayImages":{"play":{"name":"Ic\u00f4ne de lecture","url":"https:\/\/www.biotech.ca\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","path":"\/home\/biotech\/public_html\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","position":"middle_center"},"gif":{"name":"Ic\u00f4ne GIF","url":"https:\/\/www.biotech.ca\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","path":"\/home\/biotech\/public_html\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","position":"middle_center"}},"defautOgImage":"https:\/\/www.biotech.ca\/wp-content\/uploads\/2021\/12\/Logo.jpg","customPermalinks":true,"isUserRegistered":true,"autoSuggestKeywords":true,"connectSiteUrl":"https:\/\/rankmath.com\/auth?site=https%3A%2F%2Fwww.biotech.ca%2Ffr%2F&r=https%3A%2F%2Fwww.biotech.ca%2Ffr%2Fwp-json%2Fwp%2Fv2%2Fpages%2F7651%3Fnonce%3D4a61b7a4d2&pro=1","maxTags":100,"trendsIcon":"<\/svg>","showScore":true,"siteFavIcon":"https:\/\/www.biotech.ca\/wp-content\/uploads\/2021\/12\/cropped-site-icon-2-32x32.png","canUser":{"general":false,"advanced":false,"snippet":false,"social":false,"analysis":false,"analytics":false,"content_ai":false},"isPro":true,"is_front_page":false,"trendsUpgradeLink":"https:\/\/rankmath.com\/pricing\/?utm_source=Plugin&utm_medium=CE%20General%20Tab%20Trends&utm_campaign=WP","trendsUpgradeLabel":"Mettre \u00e0 niveau","trendsPreviewImage":"https:\/\/www.biotech.ca\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/trends-preview.jpg","currentEditor":false,"homepageData":{"assessor":{"powerWords":["absolument","amazement","astonishing","authentique","beau","bien-\u00eatre","brillant","captivant","charismatique","choc","clair","compl\u00e8tement","confidentiel","confiance","cons\u00e9quent","cr\u00e9atif","d\u00e9finitivement","d\u00e9licieux","d\u00e9montrer","d\u00e9p\u00eachez-vous","d\u00e9termin\u00e9","digne","dynamique","\u00e9blouissant","\u00e9clatant","\u00e9conomique","\u00e9fficace","\u00e9l\u00e9gant","\u00e9motionnel","\u00e9nergique","\u00e9norme","\u00e9poustouflant","essentiel","\u00e9tonnant","exclusif","exp\u00e9rience","fabuleux","fantastique","formidable","fort","garanti","g\u00e9ant","g\u00e9n\u00e9reux","grandiose","gratuit","habile","harmonieux","historique","hors pair","important","incroyable","indispensable","inoubliable","inspirant","innovant","intense","invention","irr\u00e9sistible","l\u00e9gendaire","lumineux","luxe","magique","magnifique","majestueux","marquant","merveilleux","miraculeux","motivant","n\u00e9cessaire","nouvelle","officiel","parfait","passionn\u00e9","persuasif","ph\u00e9nom\u00e9nal","plaisir","populaire","pouvoir","prestigieux","prodigieux","profond","prosp\u00e8re","puissant","qualit\u00e9","radieux","rapide","r\u00e9ussi","r\u00e9volutionnaire","satisfait","s\u00e9curit\u00e9","sensationnel","serein","somptueux","splendide","sublime","surprenant","talentueux","terrifiant","unique","valeur","vibrant","victorieux","vif","vraiment","z\u00e9l\u00e9"],"diacritics":true,"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasBreadcrumb":true,"serpData":{"title":"%sitename% %page% %sep% %sitedesc%","description":"","titleTemplate":"%sitename% %page% %sep% %sitedesc%","descriptionTemplate":"","focusKeywords":"","breadcrumbTitle":"Home","robots":{"index":true},"advancedRobots":{"max-snippet":"-1","max-video-preview":"-1","max-image-preview":"large"},"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":""}}},"isAnalyticsConnected":true,"tocTitle":"Table of Contents","tocExcludeHeadings":[],"listStyle":"ul"},"_links":{"self":[{"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/pages\/7651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/comments?post=7651"}],"version-history":[{"count":6,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/pages\/7651\/revisions"}],"predecessor-version":[{"id":14217,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/pages\/7651\/revisions\/14217"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/pages\/7619"}],"wp:attachment":[{"href":"https:\/\/www.biotech.ca\/fr\/wp-json\/wp\/v2\/media?parent=7651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}